Hybrid Nanoparticle for Co-delivering Paclitaxel and Dihydroartemisinin to Exhibit Synergic Anticancer Therapeutics.

Bao Ngoc TranThu Thi Kim NinhThao Thi DoPhuong Thi DoChien Ngoc Nguyen

Published in: Current cancer drug targets (2024)

Dual-drug-loaded hybrid PLGA-lecithin NP is a potential system to minimize severe side effects while enhancing antitumor efficacy, in which lyophilization is a key process to increase stability.</p>.

Keyphrases

drug delivery
small molecule
cancer therapy
early onset
drug induced
drug release
human health
risk assessment
adverse drug
climate change
electronic health record